Chromatin profiling has emerged as a powerful means of genome annotation and detection of regulatory activity. The approach is especially well suited to the characterization of non-coding portions of the genome, which critically contribute to cellular phenotypes yet remain largely uncharted. Here we map nine chromatin marks across nine cell types to systematically characterize regulatory elements, their cell-type specificities and their functional interactions. Focusing on cell-type-specific patterns of promoters and enhancers, we define multicell activity profiles for chromatin state, gene expression, regulatory motif enrichment and regulator expression. We use correlations between these profiles to link enhancers to putative target genes, and predict the cell-type-specific activators and repressors that modulate them. The resulting annotations and regulatory predictions have implications for the interpretation of genome-wide association studies. Top-scoring disease single nucleotide polymorphisms are frequently positioned within enhancer elements specifically active in relevant cell types, and in some cases affect a motif instance for a predicted regulator, thus suggesting a mechanism for the association. Our study presents a general framework for deciphering cis-regulatory connections and their roles in disease.
A major challenge in biology is understanding how a single genome can give rise to an organism comprising hundreds of distinct cell types. Much emphasis has been placed on the application of high-throughput tools to study interacting cellular components 1 . The field of systems biology has exploited dynamic gene expression patterns to reveal functional modules, pathways and networks 2 . Yet cis-regulatory elements, which may be equally dynamic, remain largely uncharted across cellular conditions.
Chromatin profiling provides a systematic means of detecting cisregulatory elements, given the central role of chromatin in mediating regulatory signals and controlling DNA access, and the paucity of recognizable sequence signals. Specific histone modifications correlate with regulator binding, transcriptional initiation and elongation, enhancer activity and repression 1, [3] [4] [5] [6] . Combinations of modifications can provide even more precise insight into chromatin state 7, 8 .
Here we apply a high-throughput pipeline to map nine chromatin marks and input controls across nine cell types. We use recurrent combinations of marks to define 15 chromatin states corresponding to repressed, poised and active promoters, strong and weak enhancers, putative insulators, transcribed regions, and large-scale repressed and inactive domains. We use directed experiments to validate biochemical and functional distinctions between states.
The resulting chromatin state maps portray a highly dynamic landscape, with the specific patterns of change across cell types revealing strong correlations between interacting functional elements. We use correlated patterns of activity between chromatin state, gene expression and regulator activity to connect enhancers to likely target genes, to predict cell-type-specific activators and repressors, and to identify individual binding motifs responsible for these interactions.
Our results have implications for the interpretation of genomewide association studies (GWASs). We find that disease variants frequently coincide with enhancer elements specific to a relevant cell type. In several cases, we can predict upstream regulators whose regulatory motif instances are affected or target genes whose expression may be altered, thereby suggesting specific mechanistic hypotheses for how disease-associated genotypes lead to the observed disease phenotypes.
Results
Systematic mapping of chromatin marks in multiple cell types To explore chromatin state in a uniform way across multiple cell types, we applied a production pipeline for chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) to generate genome-wide chromatin data sets (Methods and Fig. 1a ). We profiled nine human cell types, including common lines designated by the ENCODE consortium 1 and primary cell types. These consist of embryonic stem cells (H1 ES), erythrocytic leukaemia cells (K562), B-lymphoblastoid cells (GM12878), hepatocellular carcinoma cells (HepG2), umbilical vein endothelial cells (HUVEC), skeletal muscle myoblasts (HSMM), normal lung fibroblasts (NHLF), normal epidermal keratinocytes (NHEK) and mammary epithelial cells (HMEC).
We used antibodies for histone H3 lysine 4 trimethylation (H3K4me3), a modification associated with promoters 4, 5, 9 ; H3K4me2 (dimethylation), associated with promoters and enhancers 1, 3, 6, 9 ; H3K4me1 (methylation), preferentially associated with enhancers 1,6 ; lysine 9 acetylation (H3K9ac) and H3K27ac, associated with active regulatory regions 9, 10 ; H3K36me3 and H4K20me1, associated with transcribed regions [3] [4] [5] ; H3K27me3, associated with Polycombrepressed regions 3, 4 ; and CTCF, a sequence-specific insulator protein with diverse functions 11 . We validated each antibody by western blots and peptide competitions, and sequenced input controls for each cell type. We also collected data for H3K9me3, RNA polymerase II (RNAPII) and H2A.Z (also known as H2AFZ) in a subset of cells.
This resulted in 90 chromatin maps corresponding to ,2,400,000,000 reads covering ,100,000,000,000 bases across nine cell types, which we set out to interpret computationally.
Learning a common set of chromatin states across cell types To summarize these data sets into nine readily interpretable annotations, one per cell type, we applied a multivariate hidden Markov model that uses combinatorial patterns of chromatin marks to distinguish chromatin states 8 . The approach explicitly models mark combinations in a set of 'emission' parameters and spatial relationships between neighbouring genomic segments in a set of 'transition' parameters (Methods). It has the advantage of capturing regulatory elements with greater reliability, robustness and precision than is possible by studying individual marks 8 .
We learned chromatin states jointly by creating a virtual concatenation of all chromosomes from all cell types. We selected 15 states that showed distinct biological enrichments and were consistently recovered ( Fig. 1a, b and Supplementary Fig. 1 ). Even though states were learned de novo solely on the basis of the patterns of chromatin marks and their spatial relationships, they showed distinct associations with transcriptional start sites (TSSs), transcripts, evolutionarily conserved non-coding regions, DNase hypersensitive sites 12 , binding sites for the regulators c-Myc 13 (MYC) and NF-kB 14 , and inactive genomic regions associated with the nuclear lamina 15 (Fig. 1c ).
We distinguished six broad classes of chromatin states, which we refer to as promoter, enhancer, insulator, transcribed, repressed and inactive states ( Fig. 1c ). Within them, active, weak and poised 4 promoters (states 1-3) differ in expression level, strong and weak candidate enhancers (states 4-7) differ in expression of proximal genes, and strongly and weakly transcribed regions (states 9-11) also differ in their positional enrichments along transcripts. Similarly, Polycombrepressed regions (state 12) differ from heterochromatic and repetitive states (states [13] [14] [15] , which are also enriched for H3K9me3 (Supplementary Figs 2-4).
The states vary widely in their average segment length (,500 base pairs (bp) for promoter and enhancer states versus 10 kb for inactive for nine chromatin marks (greyscale) are shown across the WLS gene in four cell types, and summarized in a single chromatin state annotation track for each (coloured according to b). WLS is poised in ESCs, repressed in GM12878 and transcribed in HUVEC and NHLF. Its TSS switches accordingly between poised (purple), repressed (grey) and active (red) promoter states; enhancer regions within the gene body become activated (orange, yellow); and its gene body changes from low signal (white) to transcribed (green). These chromatin state changes summarize coordinated changes in many chromatin marks; for example, H3K27me3, H3K4me3 and H3K4me2 jointly mark a poised promoter, whereas loss of H3K27me3 and gain of H3K27ac and H3K9ac mark promoter activation. WCE, whole-cell extract. Bottom: nine chromatin state tracks, one per cell type, in a 900-kb region centred at WLS, summarizing 90 chromatin tracks in directly interpretable dynamic annotations and showing activation and repression patterns for six genes and hundreds of regulatory regions, including enhancer states. b, Chromatin states learned jointly across cell types by a multivariate hidden Markov model. The table shows emission parameters learned de novo on the basis of genome-wide recurrent combinations of chromatin marks. Each entry denotes the frequency with which a given mark is found at genomic positions corresponding to the chromatin state. c, Genome coverage, functional enrichments and candidate annotations for each chromatin state. Blue shading indicates intensity, scaled by column. CNV, copy number variation; GM, GM12878. d, Box plots depicting enhancer activity for predicted regulatory elements. Sequences 250 bp long corresponding either to strong or weak/poised HepG2 enhancer elements or to GM12878-specific strong enhancer elements were inserted upstream of a luciferase gene and transfected into HepG2. Reporter activity was measured in relative light units. Robust activity is seen for strong enhancers in the matched cell type, but not for weak/poised enhancers or for strong enhancers specific to a different cell type. Boxes indicate 25th, 50th and 75th percentiles, and whiskers indicate 5th and 95th percentiles.
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regions) and in the portion of the genome covered (,1% for promoter and enhancer states versus .70% for inactive state 13). For each state, coverage was relatively stable across cell types ( Supplementary Fig. 5 ), with the exception of embryonic stem cells (ESCs) in which the poised promoter state is more abundant but strong enhancer and Polycombrepressed states are depleted, consistent with the unique biology of pluripotent cells 4, 16 .
We confirmed that promoter and enhancer states showed distinct biochemical properties ( Supplementary Fig. 6 ). RNAPII was highly enriched at strong promoters, weakly enriched at strong enhancers and nearly undetectable at weak or poised enhancers, consistent with strong transcription at promoters and reports of weak transcription at active enhancers 17, 18 . H2A.Z, a histone variant associated with nucleosome-free regions 19 , was enriched in active promoters and strong enhancers, consistent with nucleosome displacement at TSSs and sites of abundant transcription factor binding in active enhancers.
We also used luciferase reporter assays to validate the functionality of predicted enhancers, the distinction between strong and weak enhancer states, and their predicted cell type specificity. We tested strong enhancers, weak enhancers and strong enhancers specific to an unmatched cell type by transfection in HepG2. We observed strong luciferase activity only for strong enhancer elements from the matched cell type (Fig. 1d) .
These results and additional properties of the model (Supplementary Figs 7-10) suggest that chromatin states are an inherent, biologically informative feature of the genome. The framework enables us to reason about coordinated differences in marks by directly studying chromatin state changes between cell types (which we refer to as 'changes' or 'dynamics' without implying any temporal relationship).
Extent and significance of chromatin state changes across cell types
We next explored the extent to which chromatin states vary between pairs of cell types. The overall patterns of variability ( Supplementary  Figs 11 and 12 ) suggest that regulatory regions vary drastically in activity level across cell types. Enhancer states show frequent interchange between strong and weak, and promoter states vary between active, weak and poised. Promoter states seem more stable than enhancers; they are eight times more likely to remain promoter states, controlling for coverage. Switching was also observed among promoter, enhancer and transcriptional transition states, but no preferential changes to other groups were found. These general patterns suggest that despite varying activity levels, enhancer and promoter regions tend to preserve their chromatin identity as regions of regulatory potential.
Chromatin state differences between cell types relate to cell-typespecific gene functions. An unbiased clustering of chromatin state profiles across annotated TSSs in lymphoblastoid and skeletal muscle cells distinguished informative patterns predictive of downstream gene expression and functional gene classes ( Supplementary Figs 13 and  14 ). Cell-type-specific patterns were also evident when TSSs were simply assigned to the most prevalent chromatin state. Promoters active in skeletal muscle were associated with extracellular structure genes (8.5fold enrichment), those active in lymphoblastoid cells were associated with immune response genes (7.2-fold enrichment) and those active in both were associated with metabolic housekeeping genes.
Clustering of promoter and enhancer states on the basis of their activity patterns Extending our pairwise promoter analysis, we clustered active promoter and strong enhancer regions across all cell types (Methods). This revealed clusters showing common activity and associated with highly coherent functions ( Fig. 2 ). For promoter clusters, these include immune response (GM12878-specific clusters, P , 10 218 ), cholesterol transport (HepG2 specific, P , 10 24 ) and metabolic processes (all cells, P , 10 2131 ). Remarkably, genes assigned to enhancer clusters by proximity also showed strong functional enrichments, including immune response (GM12878 specific, P , 10 26 ), lipid metabolism (HepG2 specific, P , 10 25 ) and angiogenesis (HUVEC specific, P , 10 23 ).
Promoters and enhancers differed in their overall specificities. The majority of promoter clusters showed activity in multiple cell types, consistent with previous work 5,10 ( Fig. 2a ). Enhancer clusters are significantly more cell type specific, with few regions showing activity in more than two cell types and a majority being specific to a single cell type ( Fig. 2b) .
We also found differences in the relative contributions of enhancerbased and promoter-based regulation among gene classes. Developmental genes seem to be strongly regulated by both, showing the highest number of proximal enhancers and diverse promoter states, including poised and Polycomb repressed ( Supplementary Fig. 15 ). Tissue-specific genes (for example immune genes and steroid metabolism genes) seem to be more dependent on enhancer regulation, showing multiple tissue-specific enhancers but less diverse promoter states. Lastly, housekeeping genes are primarily promoter regulated, with few enhancers in their vicinities.
Overall, this dynamic view of the chromatin landscape suggests that multicell chromatin profiles can be as productive for systems biology as expression analysis has traditionally been, and may hold additional information on genome regulatory programs, which we explore next.
Correlations in activity profiles link enhancers to target genes
We next investigated functional interconnections among enhancers, the factors that activate or repress them, and the genes whose expression they regulate, by defining 'activity profiles' for each across the cell types ( Fig. 3 ). We complemented these enhancer activity profiles ( Fig. 3a) with profiles for gene expression ( Fig. 3b ), sequence motif enrichment ( Fig. 3d ) and the expression of transcription factors recognizing each motif ( Fig. 3e ). We used correlations between these profiles to probabilistically link enhancers to their downstream targets and upstream regulators (Methods).
We found that patterns of enhancer activity (Figs 2b and 3a) correlated strongly with patterns of nearest-gene expression ( Fig. 3b ; correlation, .0.9 in 16 of 20 clusters). Because this correlation remained high even for large distances (.50 kb), we used activity correlation as a complement to genomic distance for linking enhancers to target genes (Methods). Activity-based linking yielded an increase in functional gene class enrichment for several clusters ( Supplementary Fig. 16 ).
We validated our approach using quantitative trait locus mapping studies that use covariation between single nucleotide polymorphism (SNP) alleles and gene expression levels to link cis-regulatory regions 
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to target genes. Investigation of four recent quantitative trait locus studies in liver 20 and lymphoblastoid cells [21] [22] [23] revealed remarkable agreement with our enhancer predictions. Enhancers linked to a given target gene by our method were significantly enriched for SNPs correlated with the gene's expression level ( Supplementary Fig. 17 ), thus confirming our enhancer-gene linkages with orthogonal data.
Correlations with transcription factor expression and motif enrichment predict upstream regulators We next predicted, on the basis of regulatory motif enrichments, sequence-specific transcription factors likely to target enhancers in a given cluster. This implicated a number of transcription factors whose known biological roles matched the respective cell types ( Fig. 3d and Supplementary Fig. 18 ). When ChIP-seq data on the relevant cell type was available, we confirmed that enriched motifs were preferentially bound by the cognate factor ( Fig. 3c ). Oct4 (POU5F1) motif instances in cluster A (ESC-specific enhancers) were preferentially bound by Oct4 in ESCs 24 , and NF-kB motif instances in cluster F (lymphoblastoid-specific enhancers) were preferentially bound by NF-kB in lymphoblastoid cells 14 . In both cases, motif instances in cell-type-specific enhancers showed a ,5-fold increase in binding in comparison with other enhancers. However, sequence-based motif enrichments do not distinguish causality. Enrichment could reflect a parallel binding event that does not affect the chromatin state, or the motif could actually be antagonistic to the enhancer state through specific repression in orthogonal cell types. To distinguish between these possibilities, we complemented the observed motif enrichments with cell-type-specific expression for the corresponding transcription factors (Fig. 3e ). We then correlated a 'motif score' based on motif enrichment in a given cluster, and a 'transcription factor expression score' based on the agreement between the transcription factor expression pattern and the cluster activity profile (Methods). A positive correlation between the two scores implies that the transcription factor may be establishing or reinforcing the chromatin state. A negative correlation would instead imply that the transcription factor may act as a repressor. For example, in addition to the enrichment of the Oct4 motif in the ESC-specific cluster A, Oct4 is specifically expressed in ESCs, leading to the prediction that it is a causal regulator of ESCs ( Fig. 3e ), consistent with known biology 16 .
For 18 of the 20 clusters, this analysis revealed one or more candidate regulators. Recovery of known roles for well-studied regulators validated our approach. For example, HNF1 (HNF1A), HNF4 (HNF4A) and PPARc (PPARG) are predicted as activators of HepG2-specific enhancers (clusters H and I), PU.1 (SPI1) and NF-kB as activators of lymphoblastoid (GM12878) enhancers (clusters C, F and G), GATA1 as an activator of K562-specific enhancers (cluster B) and Myf family members as HSMM enhancers 14, [25] [26] [27] 
The analysis also revealed potentially novel regulatory interactions. ETS-related factors (ELK1, TEL2 (ETV7) and Ets family members) are predicted activators of enhancers active in both GM12878 and HUVEC (cluster G) but not of GM12878-specific or HUVEC-specific clusters, emphasizing the value of unbiased clustering. These connections are consistent with reported roles for ETS factors in lymphopoiesis and endothelium 28 . The prediction of p53 (TP53) as an activator in HSMM, NHLF, NHEK and HMEC (clusters N, Q and R) probably reflects its maintained activity in these primary cells, as opposed to cell models in which it may be suppressed by mutation (K562) 29 , viral inactivation (GM12878) 30 or cytoplasmic localization (ESCs) 31 . A widespread role for p53 in regulating distal elements is consistent with its known binding to distal regions 32, 33 .
Our analysis also revealed several repressor signatures, including GFI1 in K562 and GM12878 (clusters B and C) and BACH2 in ESCs T  T   H1 ES  K562  GM12878  HepG2  HUVEC  HSMM  NHLF  NHEK  HMEC   size   Cluster  H1 ES  K562  GM12878  HepG2  HUVEC  HSMM  NHLF  NHEK  HMEC  Correlation   Oct4  NF-κB   TF binding   Top motifs  Oct4  Rfx  GATA  PU.1  STAT  NF-E2  NF-κB  IRF  ELK1  TEL2  Ets  HNF1  HNF4  PPARγ  TEF-1  Myf  RP58  p53  c-Myc  Mef2  AP-1  MAF  BACH1  GFI1  BACH2  CTCF  AP-4  NF-Y  HEN1  Nrf-2  ASCL2   4 4 3  2  3  2  2  2  2 
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(cluster A). Both regulators are known to repress transcription by recruiting histone deacetylases and methyltransferases to proximal promoters 34, 35 , and GFI1 has also been implicated in the silencing of satellite repeats 35 . Our regulatory inferences suggest that these regulators also modulate chromatin to inhibit enhancer activity, thus suggesting a new mechanism for distal gene regulation.
Validation of predicted binding events and regulatory outcomes The regulatory inferences above imply transcription-factor-binding events at motif instances within enhancer regions in specific cellular contexts, and we sought to validate these inferences using a general molecular signature. Binding events are associated with nucleosome displacement, a structural change evident in ChIP-seq data for histones 36 . We thus studied local depletions in the chromatin intensity profiles ('dips') as these are indicative of transcription factor binding.
We confirmed that dips were present in individual signal tracks for active enhancers and were associated with preferential sequence conservation and regulatory motif instances (Fig. 4a) .
To test our specific predictions, we superimposed chromatin profiles of coordinately regulated enhancer regions, anchoring them on the implied motif instances. Striking dips precisely coincide with regulatory motifs, and are both cell type specific and region specific, exactly as predicted (Fig. 4b, c ). Because dips only appear when the factor is expressed, they also support the identity of the trans-acting transcription factor.
To confirm that predicted causal motifs contribute to enhancer activity, we used luciferase reporters. Our model implicated HNF regulators as activators of HepG2-specific enhancers (Fig. 3) , and context-specific dips supported binding interactions (Fig. 4c ). We thus selected for functional analysis ten sites with HNF motifs showing dips in strong HepG2-specific enhancers, and evaluated them with and without the HNF motif. We found that permutation of the motif consistently led to a reduction in enhancer activity (Fig. 4d ), supporting its predicted causal role.
Assigning candidate regulatory functions to disease-associated variants Finally, we explored whether our chromatin annotations and regulatory predictions can provide insight into sequence variants associated with disease phenotypes. To that effect, we gathered a large set of noncoding SNPs from GWAS catalogues, an exceedingly small proportion of which are understood at present 37 .
We found that disease-associated SNPs are significantly more likely to coincide with strong enhancers (states 4 and 5; twofold enrichment, P , 10 210 ), despite the fact that no notable association with these states are seen for SNPs in general or for those SNPs tested in the studies. To test whether SNPs associated with a particular disease might have even more specific correspondences, we examined 426 GWAS data sets. We identified ten studies [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] whose variants showed significant correspondences to cell-type-specific strong enhancer states (Methods and Fig. 5a ).
Individual variants from these studies were strongly enriched in enhancer states specifically active in relevant cell types (Fig. 5a, b ). For example, SNPs associated with erythrocyte phenotypes 38 were found in erythrocytic leukaemia cell (K562) enhancers, SNPs associated with systemic lupus erythematosus 39 were found in lymphoblastoid cell (GM12878) enhancers and SNPs associated with triglyceride 40 phenotypes or blood lipid phenotypes 41 were found in hepatocellular carcinoma cell (HepG2) enhancers. We also applied our model to chromatin data for T cells 3 ( Supplementary Fig. 19 ), for which strong enhancer states correlated to variants associated with risk of childhood acute lymphoblastic leukaemia 48 , further validating our approach.
We also used our predicted enhancer/target gene associations to find candidate downstream genes whose expression might be affected by cis changes occurring in the enhancer region. Although most of the predicted target genes are proximal to the enhancer, a subset of more distal predicted targets could reflect novel candidates for the disease phenotypes (Fig. 5b) .
In addition, we identified several instances in which a lead GWAS variant does not correspond to a particular chromatin element but a linked variant coincides with an enhancer with the predicted cell type specificity (Fig. 5c ). Thus, chromatin profiles may provide a general means of triaging variants within a haplotype block, a common problem faced in GWASs.
Lastly, we identified several cases in which a disease-associated SNP created or disrupted a regulatory motif instance for a predicted causal transcription factor in the relevant cell type ( Fig. 5d ), suggesting a specific molecular mechanism by which the disease-associated genotype could lead to the observed disease phenotype consistent with our regulatory predictions.
Discussion
Our work demonstrates the power of multicell chromatin profiles as an additional and dynamic layer of genome annotation. We presented methods to distinguish different classes of functional elements, elucidate their cell type specificities and predict cis-regulatory interactions that drive gene expression programs. By intersecting our predictions with non-coding SNPs from GWAS data sets, we proposed potential mechanistic explanations for disease variants, either through their presence within cell-type-specific enhancer states or by their effect on binding motifs for predicted regulators.
Chromatin states drastically reduced the large combinatorial space of 90 chromatin data sets (2 90 combinations) to a manageable set of biologically interpretable annotations, thus providing an efficient and robust way to track coordinated changes across cell types. This allowed the systematic identification and comparison of more than 100,000 promoter and enhancer elements. Both types of element are cell type specific, are associated with motif enrichments and assume and enhancer activity. a, Dips in chromatin intensity profiles in a K562specific strong enhancer (orange) coincide with a predicted causal GATA motif instance (logo). The dips probably reflect nucleosome displacement associated with transcription factor binding, supported by DNase hypersensitivity 12 and GATA1 binding 25 . b, Superposition of H3K27ac signal across loci containing GATA motifs, centred on motif instances, shows dips in K562, as predicted. c, Superposition of H3K4me2 signal for HepG2 shows dips over HNF4 motifs in strong enhancer states, as predicted. d, HepG2-specific strong enhancers with predicted causal HNF motifs were tested in reporter assays. Constructs with permuted HNF motifs (red) led to significantly reduced luciferase activity in comparison with wild type (blue), with an average twofold reduction. Data shown are mean luciferase relative light units over three replicates and 95% confidence intervals.
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strong, weak and poised states that correlate with neighbouring gene expression and function. Enhancers showed very high tissue specificity, enrichment in the vicinity of developmental and cell-typespecific genes, and predictive power for proximal gene expression, reinforcing their roles as sentinels of tissue-specific gene expression 49 . By elucidating enhancers systematically, and linking them to upstream regulators and downstream genes, our analysis can help provide a missing link between regulators and target genes. The power of the approach should increase considerably as additional phenotypically distinct cell types are surveyed, and should enable a greater proportion of enhancer elements to be incorporated into the connectivity network. The inferred cis-regulatory interactions make specific testable predictions, many of which were confirmed through additional experiments and analyses. Our enhancer/target gene linkages are supported by cis-regulatory inferences from quantitative trait locus mapping studies. Predicted transcription factor/motif interactions within cell-type-specific enhancers were confirmed in specific cases by transcription factor binding and more generally by depletions in the chromatin profiles at causal motifs in appropriate cellular contexts. Motifs predicted as causal regulators of cell-type-specific enhancers were also confirmed in enhancer assays.
The regulatory inferences afforded by multicell chromatin profiles are unique and highly complementary to data sets for transcription factor binding, expression, chromatin accessibility, nucleosome positioning and chromosome conformation 50 . For example, our regulatory predictions can help focus the spectrum of transcriptionfactor-binding events to a smaller number of functional interactions. The 'chromatin-centric' approach also complements the extensive body of work on biological network inference from expression data with the potential to introduce enhancers and other genomic elements into connectivity networks.
Our study has important implications for the understanding of disease. Our detailed and dynamic functional annotations of the relatively uncharted non-coding genome can facilitate the interpretation of GWAS data sets by predicting specific cell types and regulators related to specific diseases and phenotypes. Furthermore, the connections derived for enhancer regions, to upstream regulators and downstream genes, suggest cis-and trans-acting interactions that may be modulated by the sequence variants. Although the present study represents only a first, small step in this direction, we expect that future iterations with a greater diversity of cell types and improved methodologies will help define the molecular underpinnings of human disease. HepG2  101  13  <10 -7  0.02  3 5 0 11 2 3 3 4 3   Rheumatoid arthritis  GM12878  29 2p24 with disease-associated SNPs from GWASs shows significant enrichment (blue shading) in relevant cell types (Methods). Fold enrichments of the SNPs in strong enhancer states for each cell type are indicated. FDR, false-discovery rate. b, For three GWAS data sets [38] [39] [40] , state annotations are shown for a subset of lead SNPs in the nine cell types (colours as in Fig. 1b, except state 11 is white). The strong enhancer state (orange) is most prevalent in cell types related to the phenotype. For SNPs overlapping strong enhancers, proximal genes with correlated expression are indicated, with linking score and distance. c, Example GWAS locus with blood lipid trait 41 association, where the lead variant (red circle) has no functional annotation but a linked SNP (arrow) coincides with a HepG2specific strong enhancer (orange) and may represent a causal variant. Strong enhancer annotations are shown for all cell types. d, Example GWAS loci where a disease SNP affects a conserved instance of a predicted causal motif. Left: lead SNP rs9374080 in the erythrocyte phenotype GWAS 38 is ,100 bp from a strong enhancer in K562 and strengthens a motif for GFI1B, a predicted repressor in K562 (Fig. 3e ). Right: SNP rs9271055 associated with lupus 39 coincides with a lymphoblastoid (GM12878) strong enhancer and strengthens a motif for ETS1, a predicted activator of lymphoblastoid enhancers (Fig. 3e ). This factor is further implicated by lupus-associated variants that directly affect the ETS1 locus 39 .
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METHODS SUMMARY
We performed ChIP-seq analysis in biological replicate as previously described 4 , using antibodies validated by western blots and peptide competitions. ChIP DNA and input controls were sequenced using the Illumina Genome Analyser. Expression profiles were acquired using Affymetrix GeneChip arrays. Chromatin states were learned jointly by applying a hidden Markov model 8 to ten data tracks for each of the nine cell types. We focused on a 15-state model that provides sufficient resolution to resolve biologically meaningful patterns yet is reproducible across cell types when independently processed. We used this model to produce nine genome-wide chromatin state annotations, which were validated by additional ChIP experiments and reporter assays. Multicell type clustering was conducted on locations assigned to strong promoter state 1 (or strong enhancer state 4) in at least one cell type using the k-means algorithm. We predicted enhancer/target gene linkages by correlating normalized signal intensities of H3K27ac, H3K4me1 and H3K4me2 with gene expression across cell types as a function of distance to the TSS. Upstream regulators were predicted using a set of known transcription factor motifs assembled from multiple sources. Motif instances were identified by sequence match and evolutionary conservation. We based P values for GWAS studies on randomizing the location of SNPs, and based the false-discovery rate on randomizing the assignment of SNPs across studies. Data sets are available from the ENCODE website (http://genome. ucsc.edu/ENCODE), the supporting website for this paper (http://compbio.mit.edu/ ENCODE_chromatin_states) and the Gene Expression Omnibus (GSE26386). Western blots were used to confirm specific recognition of histone protein (or CTCF). Dot plots performed using arrayed histone tail peptides representing various modification states were used to confirm specificity for the appropriate modification. ChIP-seq assays performed on a common cell reagent were used to confirm consistency between different lots of the same antibody. Chromatin immunoprecipitation. Cells were harvested by crosslinking with 1% formaldehyde in cell culture medium for 10 min at 37 uC. After quenching with the addition of 125 mM glycine for 5 min at 37 uC, the cells were washed twice with cold PBS containing protease inhibitor (Roche). After aspiration of all liquid, pellets consisting of ,10 7 cells were flash frozen and stored at 280 uC. Fixed cells were thawed and sonicated to obtain chromatin fragments of ,200 to 700 bp using a Bioruptor (Diagenode). Immunoprecipitation was performed as previously described, retaining a fraction of input 'whole-cell extract' as a control 4 . Briefly, sonicated chromatin was diluted tenfold and incubated with ,5 mg antibody overnight. Antibody-chromatin complexes were pulled-down using protein A sepharose, washed and then eluted. After crosslink reversal and proteinase K treatment, immunoprecipitated DNA was extracted with phenol, precipitated in ethanol and treated with RNase. ChIP DNA was quantified by fluorometry using the Qubit assay (Invitrogen).
Next-generation sequencing. For each ChIP or control sample, ,5 ng of DNA was used to generate a standard Illumina sequencing library. Briefly, DNA fragments were end-repaired using the End-It DNA End-Repair Kit (Epicentre), extended with a 39 'A' base using Klenow (39 R 59 exo-, 0.3 U ml 21 , NEB), ligated to standard Illumina adapters (75 bp with a 'T' overhang) using DNA ligase (0.05 U ml 21 , NEB), gel-purified on 2% agarose, retaining products between 275 and 700 bp, and subjected to 18 PCR cycles. These libraries were quantified by fluorometry and evaluated by quantitative PCR or a multiplexed-digitalhybridization-based analysis 52 (NanoString nCounter) to confirm representation and specific enrichment of DNA species. Libraries were sequenced in one or two lanes on the Illumina Genome Analyser using standard procedures for cluster amplification and sequencing by synthesis. Expression profiling. Cytosolic RNA was isolated using RNeasy Columns (Qiagen) from the same cell lots as above. Gene expression profiles were acquired using Affymetrix GeneChip arrays. The data were normalized using the GenePattern expression data analysis package 53 . CEL files were processed by RMA, quantile normalization and background correction. Two replicate expression data sets for each cell type were averaged and log 2 -transformed. Gene-level normalization across cell types was computed by mean normalization. Primary processing of sequencing reads. ChIP-seq reads were aligned to human genome build HG18 with MAQ (http://maq.sourceforge.net/maq-man.shtml) using default parameters. All reads were truncated to 36 bases before alignment. Signal density maps for visualization were derived by extending sequencing reads by 200 bp in the 39 direction (the estimated median size of ChIP fragments), and then counting the total number of overlapping reads at 25-bp intervals. Replicate ChIP-seq experiments were verified by comparing enriched intervals as previously described 4 , and were then combined into a single data set. For the hidden Markov model (HMM), density maps were derived by extending sequencing reads by 200 bp in the 39 direction and then assigning them to a single 200-bp window based on the midpoint of the extended read. These maps were then binarized at 200-bp resolution on the basis of a Poisson background model using a threshold of 10 24 . Joint learning of HMM states across cell types. To handle data from the nine cell types, we concatenated their genomes to create an extended virtual genome that we used to train the HMM. We applied the model to ten tracks corresponding to the different chromatin marks and input using a multivariate HMM as previously described 8 . Here we used a Euclidean distance for determining initial parameters for the nested initialization step. After the HMM had learned and evaluated a set of roughly nested models, considering up to 25 states, we focused on a 15-state model that provides sufficient resolution to resolve biologically meaningful chromatin patterns and yet is highly reproducible across cell types when independently processed ( Supplementary Fig. 7) . We used this model to compute the probability that each location is in a given state, and then assigned each 200-bp interval to its most likely state for each cell type. Even though our model focuses on presence/absence frequencies of marks, we found that our states also capture signal intensity differences between high-frequency and low-frequency marks ( Supplementary Fig. 9 ). Enrichment analysis. For each state, enrichments for different annotations were computed at 200-bp resolution with the exception of conservation, which was computed at nucleotide resolution. We used annotations obtained through the UCSC Genome Browser 54 for RefSeq TSSs and transcribed regions 55 , PhastCons 56 , DNase-seq for K562 cells 12 , c-Myc ChIP-seq for K562 cells 13 , NF-kB ChIP-seq for GM12878 14 , Oct4 in ESCs 24 and nuclear lamina 15 . Gene functional group enrichments were determined using STEM 57 and biological process annotations in the Gene Ontology database 58 . P values were calculated on the basis of the hypergeometric distribution and corrected for multiple testing using Bonferroni correction. Comparing chromatin state assignments between cell types. For each pair of cell types, the chromatin state assignments at each genomic position were compared. We calculated the frequency with which each pair of states occurred, and normalized this against the expected frequency based on the amount of genome covered by each state. The fold enrichments in Fig. 2a reflect an aggregation across all 72 possible pairs of cell types. Pairwise promoter clustering. Promoters for RefSeq genes were clustered on the basis of the most likely chromatin state assignment across a 2-kb region centred on the TSS. Clustering was performed jointly across GM12878 and HSMM, and was restricted to genes with corresponding Affymetrix expression. Briefly, each promoter was treated as a 330-element binary vector in which each component corresponded to a position along the promoter, cell type and state. Clustering was performed on these vectors using the k-means algorithm in MATLAB. Gene expression values were calculated on the basis of the corresponding Affymetrix probe set closest to the TSS. Multicell type promoter and enhancer clustering. Promoter state clustering was performed for all 200-bp intervals assigned to the strong promoter state (state 1) in at least one cell type. Each interval was represented by a single vector whose components are the estimated probabilities that it be in the strong promoter state for each of the nine cell types, accounting for model assignment uncertainty and biological noise. These were determined from the model posterior probabilities of state assignments and a comparison of state assignments in replicate experimental data. Clustering was performed using the k-means algorithm in MATLAB. We found that 20 clusters provided sufficient resolution to distinguish major cell-type-specific patterns. Enhancer state clustering was performed for all 200-bp intervals assigned to strong enhancer state 4 in at least one cell type using identical procedures. For the purposes of display in Fig. 2 , the locations were randomly down-sampled. For the purpose of identifying enriched functional gene categories in Fig. 2b, enhancers were linked to the nearest TSS up to 50 kb distant excluding those within 5 kb. Enhancer-gene correspondences based on the nearest gene were used for the expression analysis of distance-based linked genes in Fig. 3b . Linking enhancer locations to correlated genes. To predict linkages between enhancer states and target genes, we combined distance-based information with multicell type correlations between gene expression levels and normalized signal intensities for histone modifications associated with enhancer states (H3K4me1, H3K4me2 and H3K27ac). For each enhancer state (4-7), cell type, and 200-bp interval between 5 kb and 125 kb from the TSS, we trained logistic regression classifiers. The classifiers were trained to use mark intensity/expression correlation values to distinguish real instances of pairs of enhancer states and gene expression values from control pairs based on randomly re-assigning expression values to different genes. So that the classifiers learned a smooth and robust function at each position, we included as part of the training all enhancer state assignments within a 10-kb window centred at the position. The link score for a specific enhancer-gene linkage was defined as the ratio of the corresponding logistic regression classifier probability score to that for the randomized data.
For the evaluation of the expression quantitative trait loci (QTL) analysis, we used a link score threshold of 2.5. The expression QTL data was obtained from the University of Chicago QTL browser (http://eqtl.uchicago.edu/cgi-bin/gbrowse/ eqtl/). In the QTL evaluation, each SNP that overlapped a strong enhancer state (4 or 5), was within 125 kb of a TSS, excluding locations within 5 kb, and was associated with a gene for which we had expression data was considered eligible to be supported by our linked predictions. We computed the fraction we observed linked on the basis of our linked predictions relative to the fraction that would be expected to be linked conditioned on knowing the distance distributions of the SNPs relative to the gene TSS.
For the evaluation of linked predictions using the Gene Ontology database, we used the same link score threshold and compared gene assignments against the distance-based assignments defined above. The base set of genes in the enrichment analysis here were all genes that could be linked in at least one cluster. Motif and transcription factor analysis. A database of known transcription factor motifs was collated by combining motifs from TRANSFAC 59 (version 11.3), JASPAR 60 (2010-05-07) and protein-binding microarray data sets [61] [62] [63] . Motif instances in non-coding and non-repetitive regions of the genome were identified using these motifs and sequence conservation using a 29-way alignment of eutherian mammal genomes (K. Lindblad-Toh et al., submitted). These were filtered using a significance threshold of P , 4 28 for the motifs 64 , and a confidence level based on conservation. Motifs were linked to corresponding transcription factors using metadata provided by the source. Motif enrichments for chromatin state clusters were computed as ratios to the instances of shuffled motifs, to correct for non-specific conservation and composition. A confidence interval was calculated for each ratio using Wilson score intervals (z 5 1.5), selecting the most conservative value within the confidence interval. In cases where multiple motif variants were available for the same transcription factor, the one that showed the most variance in enrichment across clusters was selected.
For predicting causal activators and repressors, motif scores and transcription factor expression scores were correlated as follows. Motif scores were calculated as described above. Transcription factor expression scores were calculated for each cluster by correlating the expression of the transcription factor across the cell types with the activity profile of the enhancers in that cluster (defined by the cluster means from the k-means clustering). The motif scores and the transcription factor expression scores were then correlated against each other to identify positively and negatively correlated transcription factors.
Transcription factor/motif interactions predicted for strong enhancer states in specific cell types were validated by using the raw ChIP-seq tag enrichments as proxy for nucleosome positioning. For this purpose, sequencing reads were processed as above, except that the middle 75 bp of inferred ChIP fragments were used to derive signal density informative of nucleosome depletion (dips), as previously described 36 . Superposition plots show tag enrichments relative to a uniform background computed on the basis of sequencing depth.
